About SenC Bio
Our Mission
Our Technology
Our Mission
At SenC Bio, our mission is to develop novel senolytics for the treatment and prevention of cancer and other age-rellated diseases.
Our Team
Our Technology
Our Mission
Our team consists of highly skilled professionals currently employed at OHSU in the Center for Cancer Early Detection Advanced Research
Our Technology
Our Technology
Our Technology
We utilize high throughput techniques to generate novel and first-in-class drugs for targeting senescent cells.
Scientific Articles
Computational Modeling of TP63–TP53 Interaction and Rational Design of Inhibitors: Implications for Therapeutics
Molecular modelling of the FOXO4-TP53 interaction to design senolytic peptides for the elimination of senescent cancer cells
Molecular modelling of the FOXO4-TP53 interaction to design senolytic peptides for the elimination of senescent cancer cells
E. Sila Ozdemir; Michelle M. Gomes ; Jared M. Fischer
Molecular modelling of the FOXO4-TP53 interaction to design senolytic peptides for the elimination of senescent cancer cells
Molecular modelling of the FOXO4-TP53 interaction to design senolytic peptides for the elimination of senescent cancer cells
Molecular modelling of the FOXO4-TP53 interaction to design senolytic peptides for the elimination of senescent cancer cells
Hillary H Le, Suleyman S Cinaroglu, Elise C Manalo, Aysegul Ors, Michelle M Gomes, Burcin Duan Sahbaz, Karla Bonic, Carlos A Origel Marmolejo, Arnaud Quentel, Justin S Plaut, Taryn E Kawashima, E Sila Ozdemir, Sanjay V Malhotra, Yavuz Ahiska, Ugur Sezerman, Gunseli Bayram Akcapinar, Joshua C Saldivar, Emel Timucin, Jared M Fischer